By Millie P. Arora & Tamara Moellenberg

Why pharma needs to focus on improving—not just extending life.

The future of healthcare should emphasize longevity and quality of life equally, actively supporting both patients and caregivers through the years of living with chronic diseases. In an increasingly competitive market of “miracle treatments” that promise to extend lives, we see an increasing need for services that move beyond the realm of surviving, making “thriving” a key differentiator.

Read the full article on Pharmaceutical Executive.